Search

everythinglearnresearchcommunity

for

Search:↓

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

More research is needed to find a cure for hair loss after pregnancy.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Doctors often miss Hair Tourniquet Syndrome, which can lead to serious damage if not treated quickly.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Iron deficiency is not a significant cause of hair loss in women.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Rac1 is essential for proper hair structure and color.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.